COVID-19 has vividly demonstrated the risk of a catastrophic biological event. This is magnified by an increasingly interconnected world, challenged by political instability, urbanization, climate change, and new technologies that make it easier, cheaper, and faster to create and engineer pathogens.
NTI joined governments and organizations from around the world for the 2nd Global COVID-19 Summit on May 12, 2022 and committed to provide $35,000 to the pandemic preparedness and global health security financial intermediary fund.
The GHS Index highlights individual country needs, boost compliance with international standards, and create better understanding of global capabilities to prevent, detect, and respond to biological threats.
Preventing global catastrophic biological risks (GCBRS)
Advances in biotechnology outpace national governments’ ability to provide needed oversight to prevent accidents or deliberate misuse of dangerous biological agents.
Reducing biological risk and enhancing global security
Safeguarding modern bioscience and biotechnology so it can advance and flourish safely and responsibly
Rapidly assessing origins of high-consequence global biological events
A new digital report and companion summary detail the findings and recommendations developed from a tabletop exercise held by NTI | bio and the Munich Security Conference.
NTI | bio convened experts from around the world from governments, industry, and civil society in Cape Town, South Africa to discuss emerging biological risks and offer actions to address them.
NTI experts briefed government representatives at a G7 working group meeting in Berlin.
The World Bank launches a new fund to support pandemic prevention, preparedness, and response.
NTI experts make the case for establishing a new mechanism to assess biological events of unknown origin.
